We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
-0.09%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$4.54B
AUM Growth
-$145M
Cap. Flow
-$1.24B
Cap. Flow %
-27.38%
Top 10 Hldgs %
54.9%
Holding
112
New
14
Increased
17
Reduced
7
Closed
24

Top Buys

Rank Stock Value
1
BIO icon
Bio-Rad Laboratories Class A
BIO
+$67.1M
2
SGRY icon
Surgery Partners
SGRY
+$52.5M
3
IART icon
Integra LifeSciences
IART
+$47.4M
4
CNC icon
Centene
CNC
+$42.6M
5
AHCO icon
AdaptHealth
AHCO
+$30.1M

Top Sells

Rank Stock Value
1
AMED
Amedisys
AMED
+$164M
2
SILK
Silk Road Medical, Inc. Common Stock
SILK
+$36.8M
3
NAMS icon
NewAmsterdam Pharma
NAMS
+$30.1M
4
APLS
Apellis Pharmaceuticals
APLS
+$28.5M
5
COGT icon
Cogent Biosciences
COGT
+$27M

Sector Composition

Rank Sector Weight
1 Healthcare 68.01%
2 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ITOS
51
DELISTED
iTeos Therapeutics
ITOS
$7.92M 0.17%
+723,000
New +$9.25M
FUSN
52
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$7.34M 0.16%
2,823,000
– –
ALEC icon
53
Alector
ALEC
$168M
$6.84M 0.15%
1,055,192
– –
TOI icon
54
The Oncology Institute
TOI
$519M
$4.7M 0.1%
3,360,052
– –
WGS icon
55
GeneDx Holdings
WGS
$1.8B
$4.56M 0.1%
1,253,895
– –
FHTX icon
56
Foghorn Therapeutics
FHTX
$305M
$3.89M 0.09%
777,525
– –
NYXH
57
Nyxoah
NYXH
$140M
$2.82M 0.06%
400,256
-55,006
-12% -$431K
BDTX icon
58
Black Diamond Therapeutics
BDTX
$99.1M
$2.67M 0.06%
930,447
-869,553
-48% -$3.2M
ORTX
59
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$2.44M 0.05%
316,169
– –
OMIC
60
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$1.9M 0.04%
166,162
-48,867
-23% -$908K
AFIB
61
DELISTED
Acutus Medical Inc
AFIB
$1.85M 0.04%
2,660,808
– –
ANNX icon
62
Annexon
ANNX
$841M
$1.38M 0.03%
583,913
– –
CUTR
63
DELISTED
Cutera, Inc.
CUTR
$930K 0.02%
+154,406
New +$1.96M
NAMSW icon
64
NewAmsterdam Pharma Warrant
NAMSW
$87.4M
$176K ﹤0.01%
92,787
– –
CMAXW
65
DELISTED
CareMax, Inc. Warrant
CMAXW
$134K ﹤0.01%
672,000
– –
TLSIW icon
66
TriSalus Life Sciences Warrant
TLSIW
$25.5M
$127K ﹤0.01%
333,333
– –
TOIIW
67
The Oncology Institute Warrant
TOIIW
$115K ﹤0.01%
1,250,000
– –
MDVL
68
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
$100K ﹤0.01%
16,732
-1
-0% -$10
QSIAW
69
DELISTED
Quantum-Si Inc Warrant
QSIAW
$90K ﹤0.01%
333,333
– –
BFLY.WS
70
DELISTED
Butterfly Network Inc Warrants
BFLY.WS
$48.5K ﹤0.01%
733,333
– –
SIEN
71
DELISTED
Sientra, Inc.
SIEN
$27.8K ﹤0.01%
10,000
– –
SLGCW
72
DELISTED
SomaLogic, Inc. Warrant
SLGCW
$26.4K ﹤0.01%
120,000
– –
NUVB.WS
73
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
$16.7K ﹤0.01%
166,666
– –
SRZNW icon
74
Surrozen Inc Warrant
SRZNW
$75.6K
$6.85K ﹤0.01%
166,666
– –
TLSI icon
75
TriSalus Life Sciences
TLSI
$265M
$5 ﹤0.01%
+1
New +$8
1 2
3
4

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q3 2023 Portfolio in Review

As of Q3 2023, Deerfield Management held 112 positions worth $4.54B, down 3.1% from $4.68B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Deerfield Management withdrew a net $1.24B in Q3 2023, closing 24 positions and reducing 7 holdings. Its most notable exit was Amedisys, an estimated $164M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 68% of assets, down from 68% a quarter earlier, followed by Financials.

Against the trend, Deerfield Management opened a new position in Bio-Rad Laboratories Class A worth $62.4M.

  • Deerfield Management's largest Q3 2023 buy was Bio-Rad Laboratories Class A: 173,947 shares worth $62.4M.
  • Deerfield Management added most to Centene in Q3 2023, an estimated $42.6M increase.
  • Deerfield Management's biggest Q3 2023 reduction was Cogent Biosciences, cutting an estimated $27M.
  • Deerfield Management fully exited Amedisys in Q3 2023, selling an estimated $164M.
  • Deerfield Management's ten largest holdings make up 55% of its $4.54B portfolio in Q3 2023.
  • Deerfield Management opened 14 new positions and closed 24 in Q3 2023.
  • Deerfield Management's portfolio value fell 3.1% quarter-over-quarter to $4.54B.

Based on Deerfield Management's 13F filing for Q3 2023, filed 14 Nov 2023.